PME

Visage 7 Named Best in KLAS 2023

Retrieved on: 
Wednesday, February 8, 2023

SAN DIEGO, Feb. 8, 2023 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the Visage® 7 Enterprise Imaging Platform ("Visage 7") has been ranked the #1 Universal Viewer (Imaging) in the 2023 Best in KLAS ® Software & Services Report by KLAS Research ("KLAS"). Visage 7 supports the simplicity of a One Viewer™ philosophy, that enables diagnostic, clinical, specialty, research, and mobile imaging workflows from a singular platform, delivered entirely from the cloud or on premise.

Key Points: 
  • SAN DIEGO, Feb. 8, 2023 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the Visage® 7 Enterprise Imaging Platform ("Visage 7") has been ranked the #1 Universal Viewer (Imaging) in the 2023 Best in KLAS ® Software & Services Report by KLAS Research ("KLAS").
  • According to KLAS, "The Best in KLAS report recognizes software and services companies who excel in helping healthcare professionals improve patient care.
  • Visage will be receiving the 2023 Best in KLAS Award at the upcoming 2023 Healthcare Information and Management Systems Society (HIMSS) meeting, April 17-21, in Chicago, IL.
  • To schedule a discussion and demonstration of the award-winning Visage 7 in Visage Booth 4308, please click here for additional details.

Voyageurs du Monde: Profits up in 2022 and sharp increase in bookings for 2023

Retrieved on: 
Monday, February 13, 2023

Having reached the end of the 2022 financial year, the Voyageurs du Monde group expects a sharp increase in earnings in 2022 relative to 2019 (*).

Key Points: 
  • Having reached the end of the 2022 financial year, the Voyageurs du Monde group expects a sharp increase in earnings in 2022 relative to 2019 (*).
  • As expected at the time of the last announcement on 20 October 2022, sales excluding acquisitions should amount to 88% of the level achieved in 2019 (i.e.
  • Consolidated EBITDA could reach close to €45 million compared with €33.6 million in 2019, an increase of 34%.
  • The Group benefited from a sharp upturn in business, with bookings up significantly in the last three months.

Nasdaq Resumes Trading in Pingtan Marine Enterprise Ltd.

Retrieved on: 
Monday, December 19, 2022

NEW YORK, Dec. 19, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume today in Pingtan Marine Enterprise Ltd. (Nasdaq: PME) at 11:00 a.m. Eastern Time on December 19, 2022.

Key Points: 
  • NEW YORK, Dec. 19, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume today in Pingtan Marine Enterprise Ltd. (Nasdaq: PME) at 11:00 a.m. Eastern Time on December 19, 2022.
  • Trading in the company’s stock was halted on December 9, 2022 at 09:14:21 a.m. Eastern Time.
  • For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
  • For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com .

Pingtan Marine Enterprise Announces Results of Annual General Meeting

Retrieved on: 
Thursday, December 22, 2022

FUZHOU, China, Dec. 22, 2022 /PRNewswire/ -- Pingtan Marine Enterprise Ltd. (Nasdaq: PME), ("Pingtan" or the "Company"), a fishing company based in the People's Republic of China, today announced that each of the proposed resolutions submitted for shareholders' approval (the "Proposed Resolutions") as set forth in the notice of annual general meeting and the proxy statement dated October 28, 2022 (the "Notice and Proxy Statement") has been duly adopted at its annual general meeting of shareholders held in Fuzhou, China on December 14, 2022.

Key Points: 
  • FUZHOU, China, Dec. 22, 2022 /PRNewswire/ -- Pingtan Marine Enterprise Ltd. (Nasdaq: PME), ("Pingtan" or the "Company"), a fishing company based in the People's Republic of China, today announced that each of the proposed resolutions submitted for shareholders' approval (the "Proposed Resolutions") as set forth in the notice of annual general meeting and the proxy statement dated October 28, 2022 (the "Notice and Proxy Statement") has been duly adopted at its annual general meeting of shareholders held in Fuzhou, China on December 14, 2022.
  • After the adoption of the Proposed Resolutions, all corporate authorizations and actions contemplated thereunder were approved, include (1) the appointment of directors, (2) the ratification of appointment of Wei, Wei &Co, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022, (3) the Increase of Authorized Share Capital and Re-designation (as defined in the Notice and Proxy Statement), and (4) the adoption of the Second Amended and Restated Memorandum and Articles of Association.
  • Pingtan is a fishing company primarily engaging in ocean fishing through an operating subsidiary based in the PRC.
  • Pingtanconducts marine fishing operations in international with owned or licensed vessels.

Nasdaq Halts Pingtan Marine Enterprise Ltd.

Retrieved on: 
Friday, December 9, 2022

NEW YORK, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Pingtan Marine Enterprise Ltd. (Nasdaq: PME) at 09:14:21 A.M. Eastern Time for "additional information requested" from the company at a last sale price of $0.57.

Key Points: 
  • NEW YORK, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Pingtan Marine Enterprise Ltd. (Nasdaq: PME) at 09:14:21 A.M. Eastern Time for "additional information requested" from the company at a last sale price of $0.57.
  • Trading will remain halted until Pingtan Marine Enterprise Ltd. has fully satisfied Nasdaq’s request for additional information.
  • For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
  • For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com .

Metrion Biosciences and The KCNC1 Foundation Collaborate on Development of New Ion Channel Modulators for Ultra-Rare Genetic Disorder

Retrieved on: 
Wednesday, December 7, 2022

Symptoms of KCNC1 disorder include seizures during infancy, vision impairment, developmental delay, intellectual disability and many others.

Key Points: 
  • Symptoms of KCNC1 disorder include seizures during infancy, vision impairment, developmental delay, intellectual disability and many others.
  • We are very excited to collaborate with Metrion on the possibility of identifying a potential therapeutic for children with KCNC1-related disorder.
  • We welcome any contributions toward The KCNC1 Foundation as we work hard to pave a path towards a cure.
  • Dr Andrew Southan, Metrions Chief Executive, said: I would like to thank The KCNC1 Foundation for choosing Metrion to progress this discovery research programme.

Visage Announces Support of Amazon HealthLake Imaging

Retrieved on: 
Sunday, November 27, 2022

SAN DIEGO, Nov. 27, 2022 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will offer an adapter to Amazon HealthLake Imaging, a new HIPAA-eligible capability from Amazon Web Services (AWS), now available in preview. Visage will be showcasing the Visage 7 Enterprise Imaging Platform, purpose-built and engineered for CloudPACS (cloudpacs.com™), at RSNA 2022 in Chicago, the annual meeting of the Radiological Society of North America, in its booth (#4319) in McCormick Place South Hall from Sunday, November 27 – Wednesday, November 30, 2022.

Key Points: 
  • SAN DIEGO, Nov. 27, 2022 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX:PME), has announced it will offer an adapter to Amazon HealthLake Imaging , a new HIPAA-eligible capability from Amazon Web Services (AWS), now available in preview.
  • Amazon HealthLake Imaging helps automate processes for storing, accessing, and analyzing medical imaging data in the cloud at petabyte scale.
  • With Visage 7 and Amazon HealthLake Imaging, providers and researchers will have the ability to aggregate imaging data across the enterprise, making the data available when and where needed, and build cohorts for data science and AI training.
  • www.promed.com.au
    Visage, Visage Imaging, Visage Ease Pro, Visage Ease, One Viewer, ANV, CloudPACS.com, Video Reports, Load Balancer, Deep Search and Deconstructed PACS are trademarks, registered trademarks and service marks that are licensed by Visage Imaging Inc. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective owners or licensees.

Skin-like electronics could monitor your health continuously

Retrieved on: 
Wednesday, November 16, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221116005922/en/
    Wearable electronics combined with AI might one day process massive amounts of health information in real time.
  • Worn routinely, future wearable electronics could potentially detect possible emerging health problems even before obvious symptoms appear.
  • The device could also do a personalized analysis of the tracked health data while minimizing the need for its wireless transmission.
  • Stretchable electronics require that the semiconductor be a highly flexible material that is still able to conduct electricity.

Visage Leads with CloudPACS at RSNA 2022

Retrieved on: 
Monday, November 14, 2022

SAN DIEGO, Nov. 14, 2022 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will be showcasing a series of exciting new innovations, as well as the industry-leading Visage® 7 Enterprise Imaging Platform, purpose built and engineered for CloudPACS (cloudpacs.com™) at the Radiological Society of North America (RSNA) 2022 annual meeting, Booth 4319, McCormick Place South Hall (Chicago, IL) from Sunday, November 27 – Wednesday, November 30, 2022. Visage is also celebrating the release of our latest video, "The Essence of Visage".

Key Points: 
  • At RSNA 2022, in addition to highlighting the "full-stack" offerings of Visage 7 CloudPACS, Visage will demonstrate multiple new solutions, including:
    Visage 7 Workflow | Load Balancer.
  • To schedule a priority demonstration of Visage 7 at RSNA 2022, please click here for additional details.
  • If you are unable to attend RSNA 2022, but would like to schedule a demonstration of Visage 7, please click here .
  • Visage also offers modular scalability and future-proof flexibility with enterprise workflow (Visage 7 Workflow), vendor-neutral archive (Visage 7 Open Archive) and artificial intelligence (Visage AI Accelerator) solutions, all 100% native.

Voyageurs du Monde: Business picking up significantly

Retrieved on: 
Saturday, October 22, 2022

The first quarter of 2022 was impacted by the Covid pandemic, with very few departures.

Key Points: 
  • The first quarter of 2022 was impacted by the Covid pandemic, with very few departures.
  • With the health situation improving as of the second quarter, bookings and departures started to pick up as of April.
  • The board of administrators approved the financial statements for the first half of 2022 at 4.00 p.m. on 19 October 2022.
  • The shares are admitted to trading on the Euronext Growth market and eligible for PEA PME savings plans.